Lindian Resources Down 26% on Week, as Lithium & Critical Minerals Shares Cut

Lindian Resources shares (ASX: LIN) fell 26.67% over the past week to close at A$0.44, extending what has become a punishing three-month pullback of 54% from recent highs. The sell-off has been steep enough to raise questions about near-term support levels, though the stock technically remains 4.76% higher year-to-date, a reminder of just how strong early-year sentiment had been before the tide turned.

The move came as a sector review from Macquarie has a sharp blow to Lindian Resources and a group of Australian critical minerals stocks, with the rare earths developer bearing the brunt of a downgrade to Underperform and a 33% reduction in its price target.

Macquarie’s revised price target of A$0.50, down from A$0.75, now sits only marginally above the current trading price, leaving limited implied upside under the broker’s own base-case assumptions. The combination of a formal Underperform rating and a target barely above spot has done little to inspire confidence among markets, which have responded by continuing to reduce exposure.

The broader lithium and critical minerals complex also came under pressure following the same Macquarie research note. PLS Group (ASX: PLS) had its target trimmed to A$5.50 from A$6.00, IGO Ltd (ASX: IGO) to A$9.00 from A$9.50, and Liontown (ASX: LTR) to A$1.25 from A$1.50, though all three retained Outperform ratings.

Elevra Resources and Wildcat Resources (ASX: WC8) saw targets shaved to A$11.50 and A$0.80 respectively, also maintaining Outperform status. Global Lithium (ASX: GL1) was downgraded to Neutral despite receiving a target increase to A$1.15 from A$0.85, reflecting valuation concerns after a strong share price run rather than any fundamental deterioration.

Driving The Downgrade

The central issue for Lindian is not the lithium price cycle but something more specific and potentially more structurally damaging, as Macquarie removed the Kangankunde Stage 2 expansion entirely from its financial model. The broker cited regulatory uncertainty and the risk of state equity demands in Malawi as the primary reasons for this decision.

Kangankunde is widely regarded as one of the highest-grade monazite and rare earth projects globally, and Stage 2 represented a meaningful step-up in production scale and long-term cash flow generation. Stripping it from forecasts compresses the project’s long-term earnings profile considerably and reduces the valuation upside that had underpinned earlier, more optimistic price targets.

Stage 1 development at Kangankunde remains active, and Lindian continues to hold a strategically significant asset in a rare earths market that is drawing increasing geopolitical attention. Neodymium-Praseodymium (NdPr) prices have risen approximately 30% year-to-date, providing a constructive commodity backdrop for rare earth developers globally. However, that tailwind has not been sufficient to offset the company-specific regulatory concerns that Macquarie has now formally incorporated into its modelling.

Lithium Forecast Trimmed

On the lithium side, Macquarie trimmed its spodumene price forecasts by 1% to 5% across the calendar years 2026 through 2028, citing a softer medium-term supply and demand outlook. These relatively modest adjustments were nonetheless sufficient to drive meaningful earnings downgrades for the sector’s largest producers, given the leverage these companies carry to spodumene spot and contract prices. Pilbara Minerals, IGO, and Liontown were identified as facing the most significant earnings revisions as a result.

For rare earths more broadly, Lynas Rare Earths (ASX: LYC) had its target reduced to A$19.00 from A$20.00, and Iluka Resources (ASX: ILU) to A$7.20 from A$8.00, with both retaining Outperform ratings. Macquarie’s modest target trims for these names appear to reflect cost-side conservatism and valuation multiple adjustments rather than any fundamental concern about the NdPr price environment, which by most measures remains supportive.

Nickel Industries (ASX: NIC) received a target cut to A$1.20 from A$1.25 in the same note. The picture there is bifurcated: CY27 earnings per share estimates were actually upgraded by 14%, reflecting solid near-term operational performance, but CY28 and beyond saw cuts of between 16% and 26% as analysts factored in the growing weight of low-cost Indonesian processing capacity entering the global nickel supply chain.